Fuller & Thaler Asset Management’s Elevance Health ELV Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$704K	Hold	1,820	–	–	﹤0.01%	424
2026 Q1	$533K	Buy	1,820 +1	+0.1%	+$329	﹤0.01%	420
2025 Q4	$638K	Hold	1,819	–	–	﹤0.01%	417
2025 Q3	$588K	Hold	1,819	–	–	﹤0.01%	417
2025 Q2	$708K	Hold	1,819	–	–	﹤0.01%	411
2025 Q1	$791K	Hold	1,819	–	–	﹤0.01%	409
2024 Q4	$671K	Hold	1,819	–	–	﹤0.01%	435
2024 Q3	$946K	Hold	1,819	–	–	﹤0.01%	390
2024 Q2	$986K	Hold	1,819	–	–	﹤0.01%	434
2024 Q1	$943K	Hold	1,819	–	–	﹤0.01%	412
2023 Q4	$858K	Buy	1,819 +350	+24%	+$162K	﹤0.01%	403
2023 Q3	$640K	Buy	1,469 +100	+7%	+$45.4K	﹤0.01%	403
2023 Q2	$608K	Buy	1,369 +380	+38%	+$175K	﹤0.01%	409
2023 Q1	$455K	Hold	989	–	–	﹤0.01%	411
2022 Q4	$507K	Sell	989 -575	-37%	-$292K	﹤0.01%	380
2022 Q3	$710K	Sell	1,564 -550	-26%	-$263K	0.01%	381
2022 Q2	$1.02M	Sell	2,114 -1,300	-38%	-$643K	0.01%	387
2022 Q1	$1.68M	Sell	3,414 -1,100	-24%	-$503K	0.01%	380
2021 Q4	$2.09M	Sell	4,514 -600	-12%	-$252K	0.01%	360
2021 Q3	$1.91M	Sell	5,114 -400	-7%	-$152K	0.01%	360
2021 Q2	$2.1M	Sell	5,514 -900	-14%	-$344K	0.01%	350
2021 Q1	$2.3M	Sell	6,414 -1,200	-16%	-$386K	0.02%	325
2020 Q4	$2.44M	Buy	7,614 +14	+0.2%	+$4.3K	0.02%	299
2020 Q3	$2.04M	Hold	7,600	–	–	0.03%	292
2020 Q2	$2M	Hold	7,600	–	–	0.03%	283
2020 Q1	$1.73M	Buy	+7,600	New	+$2.07M	0.03%	279
2018 Q3	–	Sell	-900	Closed	-$214K	–	542
2018 Q2	$214K	Hold	900	–	–	﹤0.01%	404
2018 Q1	$198K	Sell	900 -600	-40%	-$141K	﹤0.01%	403
2017 Q4	$338K	Hold	1,500	–	–	﹤0.01%	382
2017 Q3	$285K	Buy	+1,500	New	+$285K	﹤0.01%	368
2017 Q1	–	Sell	-2,900	Closed	-$417K	–	710
2016 Q4	$417K	Hold	2,900	–	–	0.01%	311
2016 Q3	$363K	Sell	2,900 -1,100	-28%	-$142K	0.01%	290
2016 Q2	$525K	Hold	4,000	–	–	0.01%	275
2016 Q1	$556K	Sell	4,000 -1,200	-23%	-$160K	0.01%	263
2015 Q4	$725K	Sell	5,200 -1,700	-25%	-$234K	0.02%	261
2015 Q3	$966K	Buy	6,900 +2,500	+57%	+$376K	0.03%	251
2015 Q2	$722K	Sell	4,400 -1,200	-21%	-$192K	0.02%	278
2015 Q1	$865K	Sell	5,600 -4,700	-46%	-$669K	0.03%	275
2014 Q4	$1.29M	Hold	10,300	–	–	0.05%	244
2014 Q3	$1.23M	Buy	10,300 +2,200	+27%	+$252K	0.05%	249
2014 Q2	$872K	Sell	8,100 -1,900	-19%	-$196K	0.04%	275
2014 Q1	$996K	Buy	10,000 +5,500	+122%	+$497K	0.05%	267
2013 Q4	$416K	Buy	4,500 +2,200	+96%	+$195K	0.02%	323
2013 Q3	$192K	Buy	+2,300	New	+$197K	0.01%	387

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management's ELV Position: Q2 2026 in Review

Fuller & Thaler Asset Management held its Elevance Health (ELV) position steady in Q2 2026 at 1,820 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Fuller & Thaler Asset Management first reported a position in ELV in Q3 2013 and has held it in 44 quarters since. The position peaked at $2.44M in Q4 2020. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Fuller & Thaler Asset Management held 1,820 shares of Elevance Health worth $704K as of Q2 2026.
Fuller & Thaler Asset Management left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #424 holding.
Fuller & Thaler Asset Management first reported a position in Elevance Health in Q3 2013 and has held it in 44 quarters since.
Fuller & Thaler Asset Management's Elevance Health position peaked at $2.44M in Q4 2020.
1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.